| Announce Date | 11/14/2025 |
| EPS Normalized Actual | $0.13 (Beat by $0.56) |
| EPS GAAP Actual | $0.13 (Beat by $0.56) |
| Revenue Actual | $0.0358489B |
| Revenue Surprise | Beat by $35.8489M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.345 |
| EPS GAAP Estimate | $-0.345 |
| Revenue Estimate | $0.034298B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 0.5 | 11.6 | 0.49941 | 0.50059 | 1 |
| Dec 2026 | 0.25 | 23.2 | 0.24717 | 0.25283 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.86 | -0.98 | 0.0358489B | -0.7% | -0.95M |
| FQ2 2025 (Jun 2025) | -0.64 | -0.57 | 0.0309983B | 5.25% | 0.6M |
| FQ1 2025 (Mar 2025) | -0.07 | -0.03 | 0.0332125B | 7.4% | 1.71M |
| FQ4 2024 (Dec 2024) | -0.042 | -0.077 | 0.0355944B | 13.03% | 4.52M |
| FQ3 2024 (Sep 2024) | -0.0575 | -0.0875 | 0.0360992B | 17.08% | 5.46M |
| FQ2 2024 (Jun 2024) | 0.0171 | -1.32549 | 0.0293709B | 100% | -29.01M |
| FQ1 2020 (Mar 2020) | 0 | 0 | 0.0317139B | 100% | 31.71M |
| FQ2 2020 (Jun 2020) | 0 | 0 | 0.0317139B | 100% | 31.71M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.345
Consensus Revenue Estimates
0.034298B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | -0.115 | -- | -0.11521 | -0.11479 | 1 |
| FQ3 2026 (Sep 2026) | 0.01 | 8700 | 0.00998136 | 0.01001864 | 1 |
| FQ2 2026 (Jun 2026) | -0.08 | -700 | -0.08014912 | -0.07985088 | 1 |
| FQ1 2026 (Mar 2026) | -0.345 | 79.71 | -0.34564 | -0.34436 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.04B | -- | 0.04B | 0.04B | 1 |
| FQ3 2026 (Sep 2026) | 0.04B | 4.14 | 0.04B | 0.04B | 1 |
| FQ2 2026 (Jun 2026) | 0.03B | 9.08 | 0.03B | 0.03B | 1 |
| FQ1 2026 (Mar 2026) | 0.03B | 3.16 | 0.03B | 0.03B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
6
EPS # of in-lines
2
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.12 | -0.86 | -0.98 | 113.95% |
| FQ2 2025 (Jun 2025) | -0.07 | -0.64 | -0.57 | 89.06% |
| FQ1 2025 (Mar 2025) | -0.04 | -0.07 | -0.03 | 42.86% |
| FQ4 2024 (Dec 2024) | 0.035 | -0.042 | -0.077 | 183.33% |
| FQ3 2024 (Sep 2024) | 0.03 | -0.0575 | -0.0875 | 152.17% |
| FQ2 2024 (Jun 2024) | 1.34259 | 0.0171 | -1.32549 | -7751.4% |
| FQ1 2020 (Mar 2020) | 0 | 0 | NAN% | |
| FQ2 2020 (Jun 2020) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.04B | $0.04B | $-0.95M | -2.65% |
| FQ2 2025 (Jun 2025) | $0.03B | $0.03B | $0.6M | 1.93% |
| FQ1 2025 (Mar 2025) | $0.03B | $0.03B | $1.71M | 5.16% |
| FQ4 2024 (Dec 2024) | $0.03B | $0.04B | $4.52M | 12.7% |
| FQ3 2024 (Sep 2024) | $0.03B | $0.04B | $5.46M | 15.13% |
| FQ2 2024 (Jun 2024) | $0.06B | $0.03B | $-29.01M | -98.77% |
| FQ1 2020 (Mar 2020) | $0B | $0.03B | $31.71M | 100% |
| FQ2 2020 (Jun 2020) | $0B | $0.03B | $31.71M | 100% |